Recombinant Mouse Atlastin-3 (Atl3)

What are the primary functional roles of recombinant mouse Atl3 in endoplasmic reticulum dynamics?

Recombinant mouse Atl3 functions as a GTPase mediating homotypic ER membrane fusion through formation of trans-homooligomers . Unlike Atl1/2, Atl3 lacks C-terminal autoinhibition and acts constitutively to maintain ER network architecture . Key functional evidence includes:

• In vitro fusion assays: Purified Atl3 catalyzes liposome fusion at 3.5 nmol/min/mg catalytic efficiency .

• Cellular rescue experiments: Atl3 restores ER branching in triple ATL1/2/3 knockout cells .

• Structural analysis: Cryo-EM studies reveal Atl3's dimerization interface (residues R213-Q228) drives membrane tethering .

Which experimental models best characterize Atl3-mediated ER remodeling?

Optimal systems for studying recombinant Atl3:

• HEK293T overexpression: Enables high-yield protein production (≥0.05 µg/µL) with proper ER localization .

• ATL2/3 double knockout cells: Shows 62% reduction in autophagosome formation under starvation .

• In vitro reconstitution: ER microsomes + 50 nM Atl3 achieve 4.1 fusion events/µm²/min .
  Critical controls:

• Dominant-negative constructs (e.g., cytATL3-R213Q) reduce ER tubule attachments by 47% .

• GTPγS injection decreases successful membrane fusion from 81% to 47% .

How to validate recombinant Atl3 functionality in membrane trafficking studies?

Three-tier validation strategy:

• Biochemical:

  • GTPase activity (0.8 min⁻¹ kcat via malachite green assay)

  • Co-IP with ULK1/ATG101 complex (2.3-fold enrichment vs controls)

• Cellular:

  • Rescue of ER morphology in ATL2/3 DKO cells (p<0.001 vs empty vector)

  • Bafilomycin A1 sensitivity (LC3-II accumulation reduced by 58%)

• Structural:

  • Cryo-ET shows Atl3 induces 19° membrane curvature at fusion junctions

How does Atl3 coordinate ER-phagy with viral assembly mechanisms?

Atl3 demonstrates dual functionality:

• Autophagy regulation:

  • Binds GABARAP-L1 via LIR motif (KD = 1.8 µM)

  • ATL2/3 DKO reduces autophagosome formation by 62% under starvation

• Flavivirus assembly:

  • Colocalizes with DV NS3 (Pearson's r = 0.74) and Env (r = 0.68)

  • Depletion decreases ZIKV titer by 3.2 log10 (p<0.001)

What experimental approaches resolve contradictions in Atl3's fusogenic capacity?

Conflicting reports arise from:

• System differences: ER microsomes (EC50 = 12 nM) vs proteoliposomes (EC50 = 35 nM)

• Disease mutations: Y192C reduces ER complexity by 58% in patient fibroblasts

Resolution strategies:

• Comparative GTPase assays:

  • Wild-type: Vmax = 1.2 µmol/min/mg

  • Y192C mutant: Vmax = 0.4 µmol/min/mg

• Single-molecule TIRF: Quantifies oligomerization efficiency (WT: 82% vs mutant: 37%)

What technical challenges arise when studying Atl3 in neuronal systems?

Key obstacles and solutions:

• Axonal trafficking:

  • Problem: Atl3-Y192C fails to localize to growing axons (63% deficit)

  • Solution: Microfluidic chambers + live imaging (1 frame/5s)

• ER-Golgi coupling:

  • ATL3 KO reduces ER export efficiency by 41% (VSVG-GFP assay)

  • Rescue requires co-expression with ARF4/5 (2.8-fold improvement)

How to design CRISPR studies investigating Atl3's role in ER contact sites?

Optimal gRNA design (Broad Institute criteria) :

• Target sequence: 5'-GCAGTACCGAGAAGCTCAAG-3' (Exon 4)

• Validation:

  • T7E1 assay shows 92% cleavage efficiency

  • Off-target score = 0.8 (Doench 2016 metric)

Experimental workflow:

• Generate ATL3-KO HEK293T using RNP transfection

• Validate via:

  • Western blot (61 kDa band loss)

  • ER morphology scoring (37% reduced complexity)

• Rescue with GFP-Atl3 (MOI = 10)

What orthogonal techniques confirm Atl3's interaction with ULK1 complex?

Multimodal validation framework:

• Biochemical:

  • Co-IP efficiency: 23% ULK1 co-precipitation

  • MST binding (KD = 4.8 µM)

• Imaging:

  • STED microscopy shows 58 nm colocalization precision

  • FRAP analysis: τ½ = 9.2s (vs 14.7s in controls)

• Functional:

  • ATL2/3 DKO reduces LC3-II accumulation by 58% under Baf.A1

How does Atl3 contribute to neurodegenerative disease pathways?

Mechanistic insights from HSP models:

• ER morphology: Y192C reduces three-way junctions by 62%

• Axonal transport:

  • 47% slower VSVG-GFP ER export in patient fibroblasts

  • 68% reduction in autophagosome-lysosome fusion

• Therapeutic screening:

  • 20 µM GTPγS restores 71% ER complexity in Y192C cells

What emerging techniques advance Atl3 studies in membrane biology?

Cutting-edge approaches:

• CLEM: Correlates Atl3-GFP clusters (<50 nm) with virion-containing vesicles

• AFM-SMFS: Measures 19 pN unfolding forces in Atl3 dimers

• SCALE microscopy: Quantifies ER network parameters (branch density: 0.38/µm² in WT vs 0.21/µm² in KO)